73 related articles for article (PubMed ID: 3432764)
1. [Changes in platelet aggregation in patients with malignant myeloproliferative syndromes].
Mejía-Soto G; Palafox ST; Linares PG; Anaya-Galindo R
Rev Invest Clin; 1987; 39(3):227-30. PubMed ID: 3432764
[No Abstract] [Full Text] [Related]
2. Abnormalities of epinephrine-induced platelet aggregation and adenine nucleotides in myeloproliferative disorders.
Yamamoto K; Sekiguchi E; Takatani O
Thromb Haemost; 1984 Dec; 52(3):292-6. PubMed ID: 6531753
[TBL] [Abstract][Full Text] [Related]
3. [Epinephrine-induced platelet aggregation and alpha-adrenergic receptor in chronic myeloproliferative disorders].
Nagoya H
Nihon Ketsueki Gakkai Zasshi; 1984 May; 47(3):772-80. PubMed ID: 6089486
[No Abstract] [Full Text] [Related]
4. [Phospholipids and platelet procoagulant activity in myeloproliferative syndromes].
Martínez E; César J; Navarro JL; Mercado A; Pardo A; García Avello A; García Frade J
Sangre (Barc); 1985; 30(1):22-7. PubMed ID: 4039850
[No Abstract] [Full Text] [Related]
5. Abnormal platelet function in myeloproliferative disorders.
Waddell CC; Brown JA; Repinecz YA
Arch Pathol Lab Med; 1981 Aug; 105(8):432-5. PubMed ID: 6894852
[TBL] [Abstract][Full Text] [Related]
6. Abnormal aggregation and increased size of platelets in myeloproliferative disorders.
Cortelazzo S; Barbui T; Bassan R; Dini E
Thromb Haemost; 1980 Jun; 43(2):127-30. PubMed ID: 7455970
[TBL] [Abstract][Full Text] [Related]
7. In vitro platelet aggregation defects in patients with myeloproliferative disorders and high platelet counts: are they laboratory artefacts?
Grignani C; Noris P; Tinelli C; Barosi G; Balduini CL
Platelets; 2009 Mar; 20(2):131-4. PubMed ID: 19235056
[TBL] [Abstract][Full Text] [Related]
8. [Platelet function in chronic myeloproliferative syndromes associated with thrombocytosis].
Grebe G; Pereira J; Mezzano D; Legues ME; Aranda E; Lira P
Rev Med Chil; 1985 Jan; 113(1):32-7. PubMed ID: 4081383
[No Abstract] [Full Text] [Related]
9. Platelet unresponsiveness to collagen: involvement of glycoprotein Ia-IIa (alpha 2 beta 1 integrin) deficiency associated with a myeloproliferative disorder.
Handa M; Watanabe K; Kawai Y; Kamata T; Koyama T; Nagai H; Ikeda Y
Thromb Haemost; 1995 Mar; 73(3):521-8. PubMed ID: 7667837
[TBL] [Abstract][Full Text] [Related]
10. Improvement of bleeding time, platelet aggregation and platelet count during CAPD treatment.
Arends JP; Krediet RT; Boeschoten EW; van der Lelie J; Veenhof CH; von dem Borne AE
Proc Eur Dial Transplant Assoc; 1981; 18():280-5. PubMed ID: 7329972
[TBL] [Abstract][Full Text] [Related]
11. [Platelet aggregation and various coagulation parameters in liver cirrhosis].
Calabrese S; Giansante C; Sammartini C; Benedetti A
Minerva Med; 1984 Apr; 75(18):1047-52. PubMed ID: 6728255
[TBL] [Abstract][Full Text] [Related]
12. Diminished sensitivity of platelet aggregation to prostaglandin D2 in patients with myeloproliferative disorders and in patients with acute leukemia.
Wong P; Fujioka S; Yoshida S
Nihon Ketsueki Gakkai Zasshi; 1985 Feb; 48(1):147-54. PubMed ID: 3890456
[No Abstract] [Full Text] [Related]
13. Inherited heterogenous defect in platelet aggregation selectively with ADP and epinephrine--a series of 25 cases.
Saxena R; Gupta M; Gupta S; Kannan M; Ahmed RP; Choudhry VP
Indian J Pathol Microbiol; 2005 Jul; 48(3):345-8. PubMed ID: 16761747
[TBL] [Abstract][Full Text] [Related]
14. Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disorders.
Malpass TW; Savage B; Hanson SR; Slichter SJ; Harker LA
J Lab Clin Med; 1984 Jun; 103(6):894-904. PubMed ID: 6233383
[TBL] [Abstract][Full Text] [Related]
15. Platelet function in preleukaemia.
Lintula R; Rasi V; Ikkala E; Borgström GH; Vuopio P
Scand J Haematol; 1981 Jan; 26(1):65-71. PubMed ID: 7466320
[TBL] [Abstract][Full Text] [Related]
16. [Hemostasis disorders and their treatment in patients with chronic myeloproliferative diseases].
Sidorova LD; Arkhipov BF; Degtiareva MM; Barkagan LZ
Ter Arkh; 1981; 53(9):91-5. PubMed ID: 7302866
[No Abstract] [Full Text] [Related]
17. Biochemical and metabolic aspects of platelet dysfunction in chronic myeloproliferative disorders.
Pareti FI; Gugliotta L; Mannucci L; Guarini A; Mannucci PM
Thromb Haemost; 1982 Apr; 47(2):84-9. PubMed ID: 7101243
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between microvascular occlusion-like symptoms and spontaneous platelet aggregation in chronic myeloproliferative diseases (author's transl)].
Tanoue K; Nakazawa M; Nakamura H; Nagasawa T; Yoda Y; Abe T; Ijima H; Iyori S
Rinsho Ketsueki; 1981 Jul; 22(7):1123-9. PubMed ID: 7328769
[No Abstract] [Full Text] [Related]
19. [Blood platelet function in chronic myeloid-type diseases. I. Myeloproliferative diseases].
Cieslar P; Matousová O
Vnitr Lek; 1987 Nov; 33(11):998-1009. PubMed ID: 3439041
[No Abstract] [Full Text] [Related]
20. Use of whole blood platelet lumi-aggregometry to optimize anti-platelet therapy in patients with chronic myeloproliferative disorders.
Manoharan A; Gemmell R; Hartwell T
Am J Hematol; 2006 Sep; 81(9):676-83. PubMed ID: 16795055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
